Endocrine Testing Market
Endocrine Testing Market Forecasts to 2030 - Global Analysis By Test Type (Human Chorionic Gonadotropin Hormone Test, Prolactin Test, Progesterone Test and Other Test Types), Technology, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $2.8 BN |
|
Projected Year Value (2030) |
US $5.5 BN |
|
CAGR (2023 - 2030) |
10.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Endocrine Testing Market is accounted for $2.8 billion in 2023 and is expected to reach $5.5 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Endocrine testing involves the assessment of hormone levels in the body's endocrine system, which regulates various physiological functions. By determining the hormone concentrations in blood, urine, or saliva samples, this diagnostic procedure aids in the identification of hormonal imbalances or disorders. Thyroid hormones, cortisol, insulin, and reproductive hormones like testosterone and estrogen are among the hormones that are frequently tested.
According to the World Health Organization (WHO) in March 2022, 650 million adults, 340 million teenagers, and 39 million children are obese around the world and the number is still rising.
Market Dynamics:
Driver:
Rise in disorders associated with lifestyle
The increase in the endocrine related disorders is partly attributed to alterations in lifestyle patterns, like sedentary lifestyle and unhealthy eating habits. The need for diagnostic tests that can precisely identify hormonal imbalances and offer early diagnosis of such conditions has increased. Additionally, the market for endocrine testing is expected to grow as medical professionals look for cutting-edge instruments to handle the difficulties in diagnosing lifestyle-related illnesses, stressing the need for accurate and timely hormone evaluations for efficient illness treatment.
Restraint:
Errors in specimen collection
Appropriate specimen collection, storage, and transportation are critical to guaranteeing accurate hormone level measurements. Problems like incorrect sample handling, contamination, or transportation delays can damage the samples' integrity and produce inaccurate test results. Variability in outcomes may also be caused by different healthcare settings using inconsistent methods for data collection. However, it is imperative that these sample-related issues are resolved in order to preserve the accuracy and consistency of endocrine tests, underscoring the necessity of uniform procedures and training for healthcare personnel.
Opportunity:
Companion diagnostics
Companion diagnostics present a unique opportunity in the endocrine testing market by offering tailored solutions for personalized treatment in endocrine disorders. By identifying particular biomarkers or genetic markers, these diagnostics assist medical professionals in matching patients with the most appropriate treatments. This precision approach minimizes side effects, maximizes therapeutic interventions, and improves treatment outcomes in endocrine testing. Moreover, this customized approach enhances patient care while also adding to the general efficacy and affordability of endocrine-related healthcare.
Threat:
Intellectual property challenges
Intellectual property issues are brought about by the creation and application of novel testing techniques, biomarkers, and diagnostic technologies. Businesses that spend money on R&D have to worry about patent infringement because rivals might try to copy or enhance proprietary testing methods. The dynamic nature of endocrine diagnostics gives rise to inquiries concerning the extent and legitimacy of existing patents, thereby engendering conflicts concerning intellectual property rights.
Covid-19 Impact:
The endocrine testing market has been greatly affected by the COVID-19 pandemic. The endocrine system is one of the organs that the virus can affect, so there is a greater need for endocrine tests to evaluate hormonal imbalances and complications in infected individuals. The endocrine testing industry has seen a surge in innovation and research due to the need for comprehensive diagnostic solutions to comprehend the virus's impact on hormone levels. The focus on diagnosing and treating endocrine disorders has kept the endocrine testing market growing during these difficult times, despite disruptions in the healthcare system.
The immunoassay segment is expected to be the largest during the forecast period
The immunoassay segment has grown substantially because of its high sensitivity and specificity in identifying hormones and associated biomarkers. The need for precise and effective diagnostic techniques has been fueled by the rising incidence of endocrine disorders, including diabetes and thyroid issues. Furthermore, automation, the creation of new assays, and technological developments has all contributed to this segment's growth.
The insulin test segment is expected to have the highest CAGR during the forecast period
Insulin test segment is expected to have the highest CAGR during the forecast period. Insulin tests are in high demand because diabetes management greatly depends on insulin level monitoring. The sector's growth has also been aided by developments in testing technologies, such as faster and more accurate assays. Insulin test adoption has also been influenced by the growing emphasis on personalized medicine and the early detection of diabetes.
Region with largest share:
Asia Pacific region dominated the largest share due to the increasing prevalence of endocrine disorders, rising awareness about hormonal health, and advancements in healthcare infrastructure. The adoption of modern diagnostic technologies and the expansion of healthcare facilities contribute to the market's upward trajectory. Additionally, heightened investments in research and development, coupled with proactive government initiatives, further fuel the market's expansion.
Region with highest CAGR:
The market has grown profitably in North America due to rising incidence of endocrine disorders and increased public awareness of early disease detection. The region's high healthcare spending and well-established healthcare infrastructure have further stimulated market growth. Furthermore, increased R&D spending in the biotechnology and pharmaceutical industries has sparked innovation in endocrine testing techniques, which has further fuelled the regional growth.
Key players in the market
Some of the key players in Endocrine Testing market include AB Sciex, Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter, Inc., Biomedical Technologies Limited, BioMerieux SA, Bio Rad Laboratories, Inc. , Danaher Corporation, DH Tech. Dev. Pte. Ltd., DiaSorin SpA, F. Hoffmann-La Roche Ltd, Hologic Inc., Laboratory Corporation of America Holdings, Ortho Clinical Diagnostics, Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG and Thermo Fisher Scientific.
Key Developments:
In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc, a privately owned US company based in Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.
In May 2023, Hologic Inc., a global leader in women’s health, announced a partnership with recently drafted NFL cornerback Kelee Ringo and his mother, breast cancer survivor Tralee Hale, to educate women on the importance of prioritizing annual mammograms and other key health screenings.
Test Types Covered:
• Human Chorionic Gonadotropin Hormone Test
• Prolactin Test
• Progesterone Test
• Insulin Test
• Thyroid Stimulating Hormone Test
• Luteinizing Hormone Test
• Dehydroepiandrosterone Sulfate Test
• Estradiol Test
• Cortisol Test
• Testosterone Test
• Follicle Stimulating Hormone Test
• Other Test Types
Technologies Covered:
• Nucleic Acid Based
• Mass Spectroscopy
• Chromatography
• Immunoassay
• Other Technologies
End Users Covered:
• Clinical Laboratories
• Diagnostic Centers
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Endocrine Testing Market, By Test Type
5.1 Introduction
5.2 Human Chorionic Gonadotropin Hormone Test
5.3 Prolactin Test
5.4 Progesterone Test
5.5 Insulin Test
5.6 Thyroid Stimulating Hormone Test
5.7 Luteinizing Hormone Test
5.8 Dehydroepiandrosterone Sulfate Test
5.9 Estradiol Test
5.10 Cortisol Test
5.11 Testosterone Test
5.12 Follicle Stimulating Hormone Test
5.13 Other Test Types
6 Global Endocrine Testing Market, By Technology
6.1 Introduction
6.2 Nucleic Acid Based
6.3 Mass Spectroscopy
6.4 Chromatography
6.5 Immunoassay
6.6 Other Technologies
7 Global Endocrine Testing Market, By End User
7.1 Introduction
7.2 Clinical Laboratories
7.3 Diagnostic Centers
7.4 Hospitals
7.5 Other End Users
8 Global Endocrine Testing Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 AB Sciex
10.2 Abbott Laboratories
10.3 Agilent Technologies Inc.
10.4 Beckman Coulter, Inc.
10.5 Biomedical Technologies Limited
10.6 BioMerieux SA
10.7 Bio Rad Laboratories, Inc.
10.8 Danaher Corporation
10.9 DH Tech. Dev. Pte. Ltd.
10.10 DiaSorin SpA
10.11 F. Hoffmann-La Roche Ltd
10.12 Hologic Inc.
10.13 Laboratory Corporation of America Holdings
10.14 Ortho Clinical Diagnostics
10.15 Qiagen N.V.
10.16 Quest Diagnostics
10.17 Siemens Healthineers AG
10.18 Thermo Fisher Scientific
List of Tables
1 Global Endocrine Testing Market Outlook, By Region (2021-2030) ($MN)
2 Global Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
3 Global Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
4 Global Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
5 Global Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
6 Global Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
7 Global Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
8 Global Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
9 Global Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
10 Global Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
11 Global Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
12 Global Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
13 Global Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
14 Global Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
15 Global Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
16 Global Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
17 Global Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
18 Global Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
19 Global Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
20 Global Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
21 Global Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
22 Global Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
23 Global Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
24 Global Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
25 Global Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
26 North America Endocrine Testing Market Outlook, By Country (2021-2030) ($MN)
27 North America Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
28 North America Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
29 North America Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
30 North America Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
31 North America Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
32 North America Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
33 North America Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
34 North America Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
35 North America Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
36 North America Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
37 North America Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
38 North America Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
39 North America Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
40 North America Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
41 North America Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
42 North America Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
43 North America Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
44 North America Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
45 North America Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
46 North America Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
47 North America Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
48 North America Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
49 North America Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
50 North America Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
51 Europe Endocrine Testing Market Outlook, By Country (2021-2030) ($MN)
52 Europe Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
53 Europe Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
54 Europe Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
55 Europe Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
56 Europe Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
57 Europe Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
58 Europe Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
59 Europe Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
60 Europe Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
61 Europe Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
62 Europe Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
63 Europe Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
64 Europe Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
65 Europe Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
66 Europe Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
67 Europe Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
68 Europe Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
69 Europe Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
70 Europe Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
71 Europe Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
72 Europe Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
73 Europe Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
74 Europe Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
75 Europe Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
76 Asia Pacific Endocrine Testing Market Outlook, By Country (2021-2030) ($MN)
77 Asia Pacific Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
78 Asia Pacific Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
79 Asia Pacific Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
80 Asia Pacific Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
81 Asia Pacific Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
82 Asia Pacific Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
83 Asia Pacific Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
84 Asia Pacific Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
85 Asia Pacific Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
86 Asia Pacific Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
87 Asia Pacific Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
88 Asia Pacific Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
89 Asia Pacific Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
90 Asia Pacific Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
91 Asia Pacific Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
92 Asia Pacific Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
93 Asia Pacific Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
94 Asia Pacific Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
95 Asia Pacific Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
96 Asia Pacific Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
97 Asia Pacific Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
98 Asia Pacific Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
99 Asia Pacific Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
100 Asia Pacific Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
101 South America Endocrine Testing Market Outlook, By Country (2021-2030) ($MN)
102 South America Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
103 South America Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
104 South America Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
105 South America Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
106 South America Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
107 South America Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
108 South America Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
109 South America Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
110 South America Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
111 South America Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
112 South America Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
113 South America Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
114 South America Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
115 South America Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
116 South America Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
117 South America Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
118 South America Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
119 South America Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
120 South America Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
121 South America Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
122 South America Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
123 South America Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
124 South America Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
125 South America Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
126 Middle East & Africa Endocrine Testing Market Outlook, By Country (2021-2030) ($MN)
127 Middle East & Africa Endocrine Testing Market Outlook, By Test Type (2021-2030) ($MN)
128 Middle East & Africa Endocrine Testing Market Outlook, By Human Chorionic Gonadotropin Hormone Test (2021-2030) ($MN)
129 Middle East & Africa Endocrine Testing Market Outlook, By Prolactin Test (2021-2030) ($MN)
130 Middle East & Africa Endocrine Testing Market Outlook, By Progesterone Test (2021-2030) ($MN)
131 Middle East & Africa Endocrine Testing Market Outlook, By Insulin Test (2021-2030) ($MN)
132 Middle East & Africa Endocrine Testing Market Outlook, By Thyroid Stimulating Hormone Test (2021-2030) ($MN)
133 Middle East & Africa Endocrine Testing Market Outlook, By Luteinizing Hormone Test (2021-2030) ($MN)
134 Middle East & Africa Endocrine Testing Market Outlook, By Dehydroepiandrosterone Sulfate Test (2021-2030) ($MN)
135 Middle East & Africa Endocrine Testing Market Outlook, By Estradiol Test (2021-2030) ($MN)
136 Middle East & Africa Endocrine Testing Market Outlook, By Cortisol Test (2021-2030) ($MN)
137 Middle East & Africa Endocrine Testing Market Outlook, By Testosterone Test (2021-2030) ($MN)
138 Middle East & Africa Endocrine Testing Market Outlook, By Follicle Stimulating Hormone Test (2021-2030) ($MN)
139 Middle East & Africa Endocrine Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
140 Middle East & Africa Endocrine Testing Market Outlook, By Technology (2021-2030) ($MN)
141 Middle East & Africa Endocrine Testing Market Outlook, By Nucleic Acid Based (2021-2030) ($MN)
142 Middle East & Africa Endocrine Testing Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
143 Middle East & Africa Endocrine Testing Market Outlook, By Chromatography (2021-2030) ($MN)
144 Middle East & Africa Endocrine Testing Market Outlook, By Immunoassay (2021-2030) ($MN)
145 Middle East & Africa Endocrine Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
146 Middle East & Africa Endocrine Testing Market Outlook, By End User (2021-2030) ($MN)
147 Middle East & Africa Endocrine Testing Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
148 Middle East & Africa Endocrine Testing Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
149 Middle East & Africa Endocrine Testing Market Outlook, By Hospitals (2021-2030) ($MN)
150 Middle East & Africa Endocrine Testing Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
